<DOC>
	<DOCNO>NCT02611284</DOCNO>
	<brief_summary>The aim study assess efficacy feasibility new less invasive surfactant administration ( LISA ) technique specific design cannula surfactant administration use Beractant replacement preterm infant &lt; 32 week gestation compare short long term outcome intubation , administration surfactant extubation method ( INSURE ) . This single-center , prospective , open-label , non-randomized , control study experimental cohort 30 patient treat LISA retrospective control group comprise 30 recently treat patient INSURE . Beractant ( 4 ml/Kg ) administer exogenous surfactant group patient nasal continuous positive airway pressure ( nCPAP ) first three day life need 30 % fraction inspire oxygen inspire oxygen fraction ( FiO2 ) .</brief_summary>
	<brief_title>Less Invasive Beractant Administration Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Beractant</mesh_term>
	<criteria>Preterm infant less 32 week gestation ( WG ) breathe spontaneously nCPAP first three day life meet exogenous surfactant administration criterion ( Table l ) eligible enroll study Infants meet intubation criterion ( Table 1 ) moment surfactant administration exclude group .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Beractant</keyword>
	<keyword>Feasibility Studies</keyword>
	<keyword>Infant , Premature</keyword>
	<keyword>Noninvasive Ventilation</keyword>
</DOC>